Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Snap Inc (SNAP) vs Tilray Brands Inc (TLRY) Price & Performance

Snap IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Snap Inc vs Tilray Brands Inc — how do they compare? Snap Inc trades at $4.58 (market cap $7.67B), while Tilray Brands Inc trades at $4.27 (market cap $524.07M). The key difference: Snap Inc is far larger — about 14.6× Tilray Brands Inc's market cap. Which is the better fit depends on your goals.

SNAPTLRY
Market Cap
$7.67B$524.07M
Sector
MediaHealth
52-Week High
$10.35$21.00
52-Week Low
$3.93$4.23
Enterprise Value
$9.05B$621.22M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Snap Inc

No Aura AI signal available yet.

Tilray Brands Inc

TLRY trades at $4.23, down 1.63% with bearish technical signals. The company reported revenue growth to $821.31M in 2025 but faces severe profitability challenges with a net loss of $2.19B and negative margins. Recent expansion includes medical cannabis launches in Panama and strategic acquisitions, while analyst consensus shows cautious sentiment with 65% hold ratings.

The outlook remains challenging due to persistent losses and high debt levels, though expansion initiatives and potential regulatory changes offer long-term opportunities. Key risks include execution on profitability, competitive pressures, and cannabis regulatory uncertainty.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Snap Inc

Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.

Read more on SNAP

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY